Kohjin Bio Co (TSE:177A) EBITDA Margin %: 11.50% (As of Mar. 2026) — 57% Below Median


TSE:177A Kohjin Bio Co Ltd TSE:177A
19 GF Score
Price 円957.00
! 3 Warning Signs
View Full Analysis

What is Kohjin Bio Co EBITDA Margin %?

Kohjin Bio Co TSE:177A -2.15% 19 EBITDA Margin % is 11.50% as of Mar. 2026, which is 57% below its 10-year median of 27.01. GuruFocus rates TSE:177A with a GF Score™ of 19/100. The stock has 3 warning signs investors should review. Among 942 Biotechnology companies, Kohjin Bio Co ranks better than 78.87% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Kohjin Bio Co's EBITDA for the six months ended in Mar. 2026 was 円280 Mil. Kohjin Bio Co's Revenue for the six months ended in Mar. 2026 was 円2,435 Mil. Therefore, Kohjin Bio Co's EBITDA margin for the quarter that ended in Mar. 2026 was 11.50%.

Kohjin Bio Co  (TSE:177A) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Kohjin Bio Co EBITDA Margin % Related Terms

Kohjin Bio Co EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Kohjin Bio Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kohjin Bio Co EBITDA Margin % Chart

Kohjin Bio Co Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
EBITDA Margin %
28.88 30.45 20.09 27.01 15.52

Kohjin Bio Co Semi-Annual Data
Mar22 Mar23 Mar24 Sep24 Mar25 Sep25 Mar26
EBITDA Margin % Get a 7-Day Free Trial 0.00 22.20 31.48 19.42 11.50

TSE:177A vs VRTX, REGN, ALNY: EBITDA Margin % Comparison

For the Biotechnology subindustry, Kohjin Bio Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kohjin Bio Co EBITDA Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kohjin Bio Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Kohjin Bio Co's EBITDA Margin % falls into.


TSE:177A
19GF Score
Kohjin Bio Co Ltd TSE:177A
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kohjin Bio Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Kohjin Bio Co's EBITDA Margin % for the fiscal year that ended in Mar. 2026 is calculated as

EBITDA Margin %=EBITDA (A: Mar. 2026 )/Revenue (A: Mar. 2026 )
=766.46/4939.025
=15.52 %

Kohjin Bio Co's EBITDA Margin % for the quarter that ended in Mar. 2026 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=279.968/2434.545
=11.50 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 11.50% mean?
Kohjin Bio Co (TSE:177A) has a EBITDA Margin % of 11.50% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Kohjin Bio Co and its competitors. This is 57% below median its historical median of 27.01. Over the past decade, Kohjin Bio Co's EBITDA Margin % has ranged from 15.52 to 30.45. According to the industry distribution chart, Kohjin Bio Co ranks #199 out of 942 companies in the Biotechnology industry, placing it in the top 21.1%.
Is Kohjin Bio Co's EBITDA Margin % too high?
Kohjin Bio Co's current EBITDA Margin % of 11.50% is 57% below median its 10-year median of 27.01. Over the past 10 years, this metric has ranged from a low of 15.52 to a high of 30.45. Based on the distribution chart, Kohjin Bio Co ranks #199 out of 942 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Kohjin Bio Co has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Kohjin Bio Co's EBITDA Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Kohjin Bio Co ranks #199 out of 942 companies for EBITDA Margin %. This places Kohjin Bio Co in the top 21% of its industry — outperforming the majority of peers. Historically, Kohjin Bio Co's own EBITDA Margin % has ranged from 15.52 to 30.45 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Kohjin Bio Co and its competitors. Kohjin Bio Co's current EBITDA Margin % is 11.50%, which is 57% below median its own 10-year median of 27.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kohjin Bio Co stock overvalued right now?
Kohjin Bio Co (TSE:177A) has a current EBITDA Margin % of 11.50%. The current EBITDA Margin % is 11.50%, which is 57% below median its 10-year median of 27.01. Kohjin Bio Co's overall GF Score™ is 19/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Kohjin Bio Co (TSE:177A), the current EBITDA Margin % is 11.50% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kohjin Bio Co Business Description

Address 5-1-3 Chiyoda, Sakado, Saitama, JPN, 350-0214
Kohjin Bio Co Ltd is engaged in development, manufacture and sale of culture media (growing environments used for culturing microorganisms and cells) and contract manufacturing of processed cell products. It has manufacturing and sales of animal blood, sera, tissue culture media, media for microbiology testing, in vitro diagnostic agents, and cosmetics.
19GF Score

Get the complete analysis for TSE:177A

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円957.00
Price